Copyright
©The Author(s) 1998.
World J Gastroenterol. Apr 15, 1998; 4(2): 147-149
Published online Apr 15, 1998. doi: 10.3748/wjg.v4.i2.147
Published online Apr 15, 1998. doi: 10.3748/wjg.v4.i2.147
Table 3 The relationship between the tests of tumor markers and the location, size or differentiation of pancreatic cancer
Groups | Location | Size | Differentiation | |||||
Head | Body or tail | Entire | < 5.0 cm | 5 cm-9.0 cm | < 9.0 cm | Well & moderate | Poor & un-differentiated | |
POA | 9/11 (81.82) | 3/6 (50.00) | 1/3 (33.33) | 4/8 (50.00) | 8/10 (80.00) | 1/2 (50.00) | ||
mPOA | 22/27 (81.48) | 5/9 (55.56) | 2/3 (66.67) | 5/5 (100.00) | 14/19 (73.68) | 10/15 (66.67) | 10/10 (100.00) | 9/13 (69.23) |
PCAAc | 17/22 (77.27) | 4/9 (44.44) | 1/2 (50.55) | 3/4 (75.00) | 9/13 (69.23) | 3/6 (50.00) | 5/5 (100.00) | 2/4 (50.00) |
PaA | 16/22 (72.73) | 10/11 (90.91) | 2/2 (100.00) | 4/4 (100.00) | 12/15 (80.00) | 6/10 (60.00) | 8/8 (100.00) | 4/5 (80.00) |
E1 | 14/17 (82.35) | 2/6 (33.33) | 2/3 (66.67) | 6/8 (75.00) | 4/10 (40.00) | 1/2 (50.00) | 3/6 (50.00) | 2/4 (50.00) |
HPE1 | 35/41 (85.37) | 20/35 (57.14) | 7/17 (41.18) | 40/51 (78.43) | 15/25 (60.00) | 7/17 (41.18) | 43/60 (71.67) | 19/33 (57.58) |
GPDA | 14/22 (63.64) | 0/9 (0.00) | 0/2 (0.00) | 8/17 (47.06) | 3/7 (42.86) | 3/7 (42.86) | 4/7 (57.14) | 1/4 (25.00) |
RNase | 31/41 (75.61) | 24/35 (68.23) | 15/17 (88.23) | 20/29 (68.96) | 19/25 (76.00) | 15/17 (88.24) | 46/ 60 (76.67) | 24/33 (72.72) |
CA19-9 | 10/17 (58.82) | 6/8 (75.00) | 6/6 (100.00) | 7/15 (46.67) | 9/12 (75.00) | 4/4 (100.00) | 8/9 (88.89) | 8/8 (100.00) |
- Citation: Zhao XY, Yu SY, Da SP, Bai L, Guo XZ, Dai XJ, Wang YM. A clinical evaluation of serological diagnosis for pancreatic cancer. World J Gastroenterol 1998; 4(2): 147-149
- URL: https://www.wjgnet.com/1007-9327/full/v4/i2/147.htm
- DOI: https://dx.doi.org/10.3748/wjg.v4.i2.147